References:

• Statins and the vascular endothelial inflammatory response.

  Greenwood J, Mason JC.
  Trends Immunol. 2007 Feb;28(2):88-98. Epub 2007 Jan 2. Review.

• Spectrum of pleiotropic effects of statins in heart failure.

  Mathur N, Ramasubbu K, Mann DL.
  Heart Fail Clin. 2008 Apr;4(2):153-61. doi: 10.1016/j.hfc.2008.01.007. Review.

• RhoA/Rho-Kinase in the Cardiovascular System.

  Shimokawa H, Sunamura S, Satoh K.
  Circ Res. 2016 Jan 22;118(2):352-66. doi: 10.1161/CIRCRESAHA.115.306532. Review.

• Effects of statins on endothelium and signaling mechanisms.

  Endres M, Laufs U.
  Stroke. 2004 Nov;35(11 Suppl 1):2708-11. Epub 2004 Sep 16. Review.

• The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes.

  Ray KK, Cannon CP.
  J Am Coll Cardiol. 2005 Oct 18;46(8):1425-33. Review.

• Statins: a viable candidate for host-directed therapy against infectious diseases.

  Parihar SP, Guler R, Brombacher F.
  Nat Rev Immunol. 2019 Feb;19(2):104-117. doi: 10.1038/s41577-018-0094-3. Review.

• Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

  Greenwood J, Steinman L, Zamvil SS.
  Nat Rev Immunol. 2006 May;6(5):358-70. Review.